Skip to main content
SupplementScience

Epigallocatechin Gallate (EGCG) Research & Evidence

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Moderate

EGCG research is vast with over 7,000 publications. Huang et al. (2019) provided the most comprehensive meta-analysis of metabolic benefits across 41 RCTs. Kuriyama et al. (2006) published the landmark epidemiological study linking green tea consumption to reduced cardiovascular mortality in 40,000+ Japanese adults. Singh et al. (2011) reviewed EGCG's molecular mechanisms across longevity pathways. The hepatotoxicity concern is real — the USP, EFSA, and multiple case reports have documented liver injury with high-dose fasted EGCG supplementation, leading to recommendations to always take with food and stay below 800mg EGCG daily. The EGCG from matcha tea appears safer than concentrated extracts, possibly due to the presence of other protective compounds.

Evidence by Condition

ConditionStudied DoseEvidence
General antioxidant / longevity200-400mg EGCG dailyModerate
Weight management300-500mg EGCG dailyModerate
Cardiovascular support200-400mg EGCG dailyModerate

References

  1. (). The anti-obesity effects of green tea in human intervention and basic molecular studies. European Journal of Clinical Nutrition. DOI
  2. (). Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan. JAMA. DOI
  3. (). Hepatotoxicity of green tea: an update. Archives of Toxicology. DOI